Overview Fundamentals Financials Technicals Corporate Action Shareholding Pattern Peer Comparison News Stock Analysis About Company FAQs

Abbott India Ltd Share Price

Pharmaceuticals - Multinational

NSE: ABBOTINDIA Mid Cap ISIN: INE358A01014
As on 31 January 2025 at 13:49 IST
As on 31 January 2025 at 13:49 IST
26,076.45
-52.95
(-0.20%)
About Abbott India Ltd

Abbott India Limited provides diagnostics solutions, medical devices, nutritional products, and pharmaceuticals. Founded in 1910, Abbott India has many years of experience in healthcare. This makes it a longstanding player in the industry. Its headquarters are located in Mumbai, Maharashtra. Main products include diagnostics solutions, medical devices, and pharmaceuticals. Abbott India operates in the healthcare sector. It is contributing significantly to the industry through its diverse product offerings and commitment to innovation and quality. The company also engages in corporate social responsibility initiatives. It supports community development programs and environmental sustainability projects. Read More...

Over 1 Month
-12.33%
Over 6 Months
-7.24%
Over 1 Year
2.43%
Over 3 Years
62.50%

Abbott India Ltd Summary

Close ₹ 26,076.45
Open ₹ 25,937.50
High ₹ 26,342.95
Low ₹ 25,937.50
Volume 4,513
Net Turnover (in ₹ Cr) ₹ 19.64
52Wk High ₹ 30,668
52Wk Low ₹ 25,200
52Wk High / Low
25,200
30,668

Abbott India Ltd Fundamentals

Key Financial Data

Market Cap (in ₹Cr) ₹ 55,524.98
EPS (TTM) 604.55
Book Value (BV) 1,656.99
Div. Yield 1.57 %
P/E (TTM) 43.16
Price/Book Value 15.75
Delivery % 29.61 %
Face Value 10

Key Ratios

PE Ratio 47.67
PB Ratio 15.48
EV to Sales 9.40
PEG Ratio 1.80
ROA 30.82
ROE 34.88
Debt-Equity 0.03
Net Profit Margin 20.45
Operating Profit Margin 28.96

Abbott India Ltd Financials

Profit and Loss

No data available

Balance Sheet

No data available

Cash Flow

No data available

Particulars (in ₹ Cr.) FY 2024FY 2023FY 2022FY 2021FY 2020
Total Revenue6,097.185,502.884,996.484,390.924,207.53
Total Expenses4,479.434,229.063,916.753,464.973,404.83
Profit Before Tax1,617.751,273.821,079.73925.95802.70
Profit After Tax1,201.22949.41798.70690.69592.93
Operating Profit after Depreciation1,630.201,289.811,098.83944.23811.23

Balance Sheet

Particulars (in ₹ Cr.) FY 2024FY 2023FY 2022FY 2021FY 2020
Fixed Assets224.94236.91271250.78269.83
Total Non Current Assets1,947.651,530.40371.08353.04342.20
Total Current Assets3,245.843,025.113,853.043,487.413,204.65
TOTAL ASSETS5,193.494,555.514,224.123,840.453,546.85
Total Shareholder's Fund3,698.893,188.542,819.792,602.162,431.70

Cash Flow

Particulars (in ₹ Cr.) FY 2024FY 2023FY 2022FY 2021FY 2020
Net Cash from Operating Activities1,212.81893.39947.66726.74626.13
Net Cash used in Investing Activities-416.03-147.71-395.84-71.82-401.21
Net Cash used in Financing Activities-744.71-638.72-637.38-581.79-216.79

No data available

Particulars (in ₹ Cr.) 2024-09 2024-06 2024-03 2023-12 2023-09
Total Revenue1,632.671,557.611,438.631,437.141,494.14
Total Expenses1,193.711,166.601,109.101,049.451,113.26
Profit Before Tax479.43437.22389.68422.16415.42
Profit After Tax358.61328.01287.06310.98312.94
Operating Profit after Depreciation499.44458.34410.68443.30436.39

Abbott India Ltd Technicals

Support and Resistance

S3 S2 S1 Pivot R1 R2 R3
S1 25,722.70
S2 25,316
S3 25,077.35
Pivot 25,961.35
R1 26,368.05
R2 26,606.70
R3 27,013.40

Moving Average

20 SMA 27,968.39
50 SMA 28,327.50
100 SMA 28,507.39
200 SMA 27,961.63

Abbott India Ltd Corporate Actions

Abbott India Ltd

₹410/Share

Announcement Date 19 Jul 2024
Record Date 19 Jul 2024
Div Yield 4100%

Abbott India Ltd Peer Comparison

Company Price Market Cap (in ₹ Cr)
Abbott India Ltd ₹26,094.85 ₹55,451.56
Sun Pharmaceuticals Industries Ltd ₹1,745.25 ₹4,18,743.94
Divis Laboratories Ltd ₹5,733.60 ₹1,52,209.07
Cipla Ltd ₹1,458.15 ₹1,17,762.24
Torrent Pharmaceuticals Ltd ₹3,357.15 ₹1,13,616.11
Mankind Pharma Ltd ₹2,488.40 ₹1,02,663.15

Abbott India Ltd News

Abbott India to hold board meeting

On 5 February 2025

28 Jan 2025, 03:04 pm

Abbott India Ltd down for fifth straight session

Abbott India Ltd is quoting at Rs 27173.55, down 2.06% on the day as on 13:19 IST on the NSE. The stock jumped 5.61% in last one year as compared to a 8.09% rally in NIFTY and a 27.33% spurt in the Nifty Pharma index.

16 Jan 2025, 01:35 pm

Abbott India appoints director

With effect from 03 January 2025

03 Jan 2025, 01:00 pm

Abbott India director resigns

With effect from 25 February 2025

03 Jan 2025, 12:59 pm

Abbott India Ltd soars 2.36%, Gains for third straight session

Abbott India Ltd is quoting at Rs 29954.7, up 2.36% on the day as on 12:49 IST on the NSE. The stock is up 31.6% in last one year as compared to a 9.48% gain in NIFTY and a 37.57% gain in the Nifty Pharma index.

30 Dec 2024, 01:05 pm

Abbott India Ltd Stock Analysis

  1. Annual revenue for Abbott India Ltd increased by 10.80% to ₹6,097.18 crore in FY 2024 from ₹5,502.88 crore in FY 2023.
  2. Annual Net Profit for Abbott India Ltd increased by 26.52% to ₹1,201.22 crore in FY 2024 from ₹949.41 crore in FY 2023.
  3. Promoter Shareholding in Abbott India Ltd remains unchanged by 0.00% in the most recent quarter, from 74.99% in September 2024 to 74.99% in December 2024.
  4. Abbott India Ltd delivered a 1-year return of 2.43% compared to the Nifty 50, which provided a return of 8.03% as of the last trading session.
  5. Abbott India Ltd share price moved down by 0.20% from its previous close of INR ₹26,129.40. The latest Abbott India Ltd share price is INR ₹26,076.45.
  6. Abbott India Ltd share price today has been at a low of 25,937.50 and a high of 26,342.95. Over the past 52 weeks, the Abbott India Ltd share price has seen a low of 25,200 and a high of 30,668.

About Abbott India Ltd

Abbott India Limited is a leading healthcare company. It offers a diverse range of diagnostics solutions and medical devices. The company also offers nutritional products and established pharmaceuticals. Established in 1910, Abbott India has a rich history of many decades in the healthcare sector. The company’s headquarters are located in Mumbai, Maharashtra, India.

The company is a subsidiary of Abbott Laboratories, an American healthcare giant. Abbott India benefits from a global network of expertise and innovation. The company provides products across various therapeutic categories. This includes women’s health and gastroenterology. It also includes cardiology, metabolic disorders, and primary care. Its main offerings include diagnostics solutions and medical devices. Along with that, it offers nutritional products and a range of pharmaceuticals.

It is a significant player in the healthcare sector. It holds a considerable position in the Indian healthcare market. Its success is driven by its commitment to quality and innovation. Abbott Laboratories, the parent company, holds a significant shareholding in Abbott India at 74.99%. This fact underscores the strategic importance of the Indian market to its global operations.
Here are the primary promoters of the company:
  • Munir Shaikh
  • Swati Dalal
  • Kaiyomarz Marfatia
  • Ambati Venu
  • Sabina Ewing

The registered office of Abbott India is located in Mumbai, Maharashtra. The registrar of the company isKFin Technologies Ltd. The management team includes experienced professionals guided by a dedicated Board of Directors. The team ensures robust governance and strategic direction. Abbott India continues to make significant strides in the healthcare industry. It has been contributing to improved health outcomes for millions of people in India.

Background of the Company

Abbott India Limited was established in 1910. It is one of the oldest and most respected healthcare companies in India. Headquartered in Mumbai, Maharashtra, Abbott India is a subsidiary of Abbott Laboratories, an American healthcare giant. Over the past many years, Abbott India has been dedicated to improving health and well-being. They do this through diverse science-based nutritional products and diagnostic tools. It also provides branded generic pharmaceuticals, and diabetes and vascular devices.

The company’s journey began with a commitment to providing high-quality healthcare solutions to the Indian market. Abbott India has grown significantly over the years, becoming a key player in the Indian healthcare industry. The company offers products across various therapeutic categories. This includes women’s health, gastroenterology and cardiology. It also provides products for metabolic disorders and primary care. Its main products include diagnostics solutions and medical devices. The list also includes nutritional products and a range of pharmaceuticals.

Abbott India’s mission is to help people live healthier lives by providing reliable and innovative healthcare solutions. The company’s products are known for their quality and efficacy. They play a crucial role in improving health outcomes for millions of people in India. Abbott India’s commitment to excellence is reflected in its robust product development. It is also evident in the company’s manufacturing, sales, and customer service processes.

A dedicated Board of Directors guides the company’s leadership team. They ensure that Abbott India continues to uphold its high standards of quality and innovation. The management team includes experienced professionals who are passionate about making a positive impact on healthcare in India.

Abbott India’s registered office is located at Sion Trombay Road, Mumbai, Maharashtra 4000714. Abbott India Limited was incorporated initially as Boots Pure Drug Company (India) Limited on August 22, 1944. It has a rich history of many decades. The company underwent several name changes, becoming The Boots Company (India) Limited in 1971. It finally adopted its current name, Abbott India Limited, on July 1, 2002. Abbott India is a subsidiary of Abbott Laboratories, an American healthcare giant. It is headquartered in Mumbai, Maharashtra.

Over the years, Abbott India has expanded its product portfolio to include diagnostics solutions, medical devices and nutritional products. The portfolio also includes pharmaceuticals across various therapeutic categories. The company’s commitment to quality and innovation has made it a trusted name in the Indian healthcare market. Abbott India’s extensive research and development efforts ensure that it stays at the forefront of medical advancements. It is continually improving its offerings to serve the healthcare needs of the community better.

A dedicated Board of Directors leads Abbott India’s leadership team. They play a crucial role in guiding the company’s strategic direction and maintaining its high standards. The management team comprises experienced professionals who are passionate about making a positive impact on healthcare in India. Their collective expertise and commitment to excellence drive Abbott India’s success and growth. Abbott India continues to be a leading force in the Indian healthcare industry. It is dedicated to improving health outcomes and enhancing the quality of life for millions of people.

Abbott India Limited has a rich history of many years, marked by its commitment to providing high-quality healthcare solutions. As a subsidiary of Abbott Laboratories, the company continues to play a vital role in the Indian healthcare market. It continues to contribute to improved health outcomes and well-being for millions of people.

FAQ’s

What is the share price of Abbott India Ltd today?

Abbott India Ltd share price as on 31 Jan 2025 is ₹ 26076.45

What is the Market Cap of Abbott India Ltd?

The market cap of Abbott India Ltd stock is ₹55,524.98 Cr.

What is the PE Ratio of Abbott India Ltd?

The Price to Earnings (P/E) Ratio of Abbott India Ltd is 47.67

What is the PB Ratio of Abbott India Ltd?

The Price to Book (P/B) Ratio of Abbott India Ltd is 15.48

What is the 52 week high of Abbott India Ltd Share Price?

The 52 week high of Abbott India Ltd share price stands at ₹30,668

What is the 52 week low of Abbott India Ltd Share Price?

The 52 week low of Abbott India Ltd share price stands at ₹25,200

Get started with us today and
start building your wealth journey